Comprehensive MMC/VICC Cancer Research Partnership

描述（由申请人提供） 众所周知，少数群体患癌症的比例很高 在死亡率和发病率方面存在差异。其他 公认的问题是少数民族科学家和医生的缺乏 从事癌症研究的少数民族人数不成比例， 进入临床试验。梅哈里医学院（MMC）有一个 杰出的历史培训了很大一部分非洲裔美国人 目前活跃在美国的医生。虽然MMC长期以来 积极参与癌症研究，这些活动的承诺尚未达到 结果Vanderbilt-Ingram癌症中心（VICC）是一家研究密集型的国家癌症研究所， 癌症中心有非常强大的基础，翻译，临床， 预防和基于人口的研究计划。MMC和VICC位于 在纳什维尔相隔两英里由来已久 两个机构之间的教师互动，以及最近 Meharry-Vanderbilt联盟的建立提供了 快速发展MSI/CC伙伴关系的基础设施， CCSG的补充。本U 54应用程序的总体目标是 加强和扩大现有的癌症研究伙伴关系， MMC和VICC实现三个目的：（1）增加和稳定 MMC具有竞争力的癌症研究能力;（2）创造稳定，长期 MMC和VICC在癌症研究中的合作关系， 研究培训和职业发展;（3）改善 监测委员会和维也纳国际中心开展活动的有效性， 少数群体的发病率、死亡率和发病率 中南。我们为实现这些目标而设计的计划是 每个机构的行政管理和规划工作， 评价该项目的研究活动载于 发展核心，包括基础科学，癌症， 预防、结果和推广以及临床研究。我们提出 为六个试点项目和四个共享资源提供资金。两个基本 科学家，一名医学肿瘤学家，一名外科肿瘤学家和两名 流行病学家，将被招募加入MMC教师与联合 范德比尔特的任命。我们提出 通过正式的培训计划和 培训一名少数民族肿瘤内科医生、少数民族研究护士和数据 经理少数族裔博士候选人和MMC医学生在基础和 临床癌症研究。

DESCRIPTION (provided by applicant) It is well known that minority groups suffer disproportionately from cancers with disparities existing in both the mortality and incidence rates. Other well-recognized problems are the paucity of minority scientists and physicians working in cancer research and the disproportionate number of minorities being entered into clinical trials. Meharry Medical College (MMC) has a distinguished history of training a large percentage of the African American physicians currently active in the United States. While MMC has long been active in cancer research, the promise of these activities has not yet reached fruition. Vanderbilt-Ingram Cancer Center (VICC) is a research intensive NCI-designated cancer center with very strong basic, translational, clinical, prevention and population-based research programs. MMC and VICC are located approximately two miles apart within Nashville. There has been a long history of faculty interactions between the two institutions, and the more recent establishment of the Meharry-Vanderbilt Alliance has provided the infrastructure for the rapid development of a MSI/CC partnership with support from the CCSG supplement. The overall objectives of this U54 application are to strengthen and expand the existing partnership for cancer research between MMC and the VICC to achieve three ends: (1) to increase and stabilize the competitive cancer research capability of MMC; (2) to create stable, long term collaborative relationships between MMC and the VICC in cancer research, research training and career development; and, (3) to improve the effectiveness of MMC and the VICC in conducting activities focused on the disproportionate incidence, mortality and morbidity in minority populations in the mid-south. The programs we have designed to achieve these ends are guided by modest cores for administration at each institution and for planning and evaluation. Research activities for the project are contained in a development core that consists of components in basic science, cancer prevention, outcomes and outreach, and clinical investigations. We propose funding of six pilot projects and four shared resources. Two basic scientists, one medical oncologist one surgical oncologists and two epidemiologists, will be recruited to join the MMC faculty with joint appointments at Vanderbilt under the auspices of this grant. We propose career development of MMC faculty through formal training programs and training of a minority medical oncologist, minority research nurses and data managers, minority Ph.D. candidates, and MMC medical students in basic and clinical cancer research.